ArticleDrug testing and analysis2026
Exploring Cerumen as an Alternative Matrix for Drug Detection and Quantification: Method Development and Application in Clinical Samples.
Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cerumen (earwax) is a complex mix of apocrine and holocrine secretions and skin cells. In recent years, it has emerged as an innovative specimen for the detection of xenobiotics, suggesting that it has both clinical and forensic applications. An LC-MS/MS method was developed for the detection of 33 psychoactive medications in cerumen and urine and applied to samples from 60 psychiatric inpatient volunteers. The history of administration and qualitative results between urine and cerumen were generally consistent, with haloperidol, quetiapine, and nebivolol being detected more frequently in cerumen. In certain cases, drugs were detected both with very recent and without any recent administration, even when they were not in urine, highlighting opportunities for utilization in monitoring both acute and chronic administration and even following the cessation of administration. However, no clear relationship was found between drug concentrations and time of administration or total daily dose in most cases, consistent with challenges of routine collection. Cerumen concentrations were higher among more hydrophilic drugs with lower molecular weight and protein binding and demonstrated the best fit with an inverse regression model. No relationship was found with patient sex. Our results suggest that the disposition of drugs in cerumen is complex, being downstream of insufficiently elucidated pathways through migrating skin cells, ceruminous, and sebaceous glands. The present study is the first to investigate the routine collection of cerumen in a clinical setting and has broad implications for the interpretation of drug testing results with this emerging alternative biological specimen.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.